How informative are open-label studies for youth with bipolar disorder? A meta-analysis comparing open-label versus randomized, placebo-controlled clinical trials

Journal of Clinical Psychiatry

Volumn 73, Issue 3, 2012, Pages 358-365

  Biederman, Joseph ^a,b   Petty, Carter R ^a   Woodworth, K Yvonne ^a   Lomedico, Alexandra ^a   O'Connor, Katherine B ^a   Wozniak, Janet ^a,b   Faraone, Stephen V ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; ZIPRASIDONE;

BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; HUMAN; MONOTHERAPY; OPEN STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; YOUNG MANIA RATING SCALE;

EID: 84859120551     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06490     Document Type: Review

References (30)

1. Mick E, Biederman J, Faraone SV, et al. Defining adevelopmental subtype of bipolar disorder in a sample of nonreferred adults by age at onset. J Child Adolesc Psychopharmacol. 2003;13(4):453-462. doi:10.1089/104546032724841 PubMed (Pubitemid 38174235)
2. Perlis RH, Miyahara S, Marangell LB, et al STEP-BD Investigators. Longterm implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881. doi:10.1016/j.biopsych. 204.01.02 PubMed (Pubitemid 38526299)
3. Geller B, Tillman R. Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria. J Clin Psychiatry. 2005;66(suppl 7):21-28. PubMed (Pubitemid 41345491)
4. Biederman J, Mick E, Faraone SV, et al. A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder. J Affect Disord. 2004;82(suppl 1):S17-S23. doi:10.1016/j.jad.204.05. 012 PubMed (Pubitemid 39574980)
5. Birmaher B, Axelson D, Strober M, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63(2):175-183. doi:10.101/archpsyc.63.2.175 PubMed (Pubitemid 43213879)
6. Geller B, Bolhofner K, Craney JL, et al. Psychosocial functioning in aprepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry. 2000;39(12):1543-1548. doi:10.1097/04583-20120-018 PubMed
7. Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry. 1995;34(7):867-876. doi:10.1097/04583-195070-010 PubMed
8. Biederman J. Pediatric bipolar disorder coming of age. Biol Psychiatry. 2003;53(11):931-934. doi:10.1016/S06-323(03)0297-X PubMed (Pubitemid 36645222)
9. Youngstrom EA, Birmaher B, Findling RL. Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord. 2008;10(1, pt 2):194-214. doi:10.1/j.139-5618.207.0563.x PubMed
10. Biederman J, Mick E, Prince J, et al. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol. 1999;9(4):247-256. doi:10.1089/cap.19.9.247 PubMed (Pubitemid 30005079)
11. Biederman J, McDonnell MA, Wozniak J, et al. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr. 2005;10(2):141-148. PubMed (Pubitemid 40327779)
12. Biederman J, Mick E, Bostic JQ, et al. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. J Clin Psychiatry. 1998;59(11):628-637, quiz 638. doi:10.408/JCP.v59n1 PubMed
13. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(6): 713-720. doi:10.1097/04583-2060-09 PubMed (Pubitemid 30351221)
14. Wagner KD, Weller EB, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1224-1230. doi:10.1097/04583-20210-012 PubMed (Pubitemid 38338042)
15. Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001;11(3):239-250. doi:10.1089/104546015259568 PubMed (Pubitemid 32937636)
16. Biederman J, Mick E, Hammerness P, et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry. 2005;58(7):589-594. doi:10.1016/j.biopsych.205.03.019 PubMed (Pubitemid 41457306)
17. DelBello MP, Versavel M, Ice K, et al. Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. J Child Adolesc Psychopharmacol. 2008;18(5):491-499. doi:10.1089/cap.208.08 PubMed
18. Friedman L, Furberg C, DeMets D. Fundamentals of Clinical Trials. 3rd Edition. New York, NY: Springer-Verlag; 1998.
19. Haas M, Delbello MP, Pandina G, et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2009;11(7):687-700. doi:10.1/j.139-5618.209.0750.x PubMed
20. Briefing Document for Psychopharmacologic Drugs Advisory Committee (PDAC) Meeting of June 9-10, 2009. Safety and efficacy supplement to NDA 20-825 regarding the treatment of pediatric patients with bipolar I disorder. Study A1281132. http://www.fda.gov/ downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ PsychopharmacologicDrugsAdvisoryCommittee/ UCM170736.pdf. Updated May 4, 2009. Accessed September 1, 2011.
21. Advisory Committee Briefing Document for Psychopharmacologic Drugs Advisory Committee Meeting of June 9-10, 2009: Efficacy and safety of Study 149 (D1441C00149) http://www.fda.gov/ downloads/advisorycommittees/ committeesmeetingmaterials/drugs/ psychopharmacologicdrugsadvisorycommittee/ ucm164280.pdf. Updated May 12, 2009. Accessed September 1, 2011.
22. Tohen M, Kryzhanovskaya L, Carlson G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry. 2007;164(10):1547-1556. doi:10.176/api.ajp.207.061932 PubMed (Pubitemid 350069734)
23. Tramontina S, Zeni CP, Ketzer CR, et al. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/ hyperactivity disorder: a pilot randomized clinical trial. J Clin Psychiatry. 2009;70(5):756-764. doi:10.408/JCP.08m04726 PubMed
24. Wagner KD, Redden L, Kowatch RA, et al. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48(5):519-532. doi:10.1097/CHI.0b013e31819c5ec PubMed
25. Biederman J, Mick E, Wozniak J, et al. An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2005;15(2):311-317. doi:10.1089/cap.205.15.31 PubMed (Pubitemid 40734110)
26. Biederman J, Mick E, Spencer T, et al. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr. 2007;12(9):683-689. PubMed (Pubitemid 47571968)
27. Biederman J, Mick E, Spencer T, et al. A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord. 2007;9(8):888-894. doi:10.1/j.139-5618.207.0450.x PubMed (Pubitemid 350215115)
28. Wozniak J, Mick E, Waxmonsky J, et al. Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. J Child Adolesc Psychopharmacol. 2009;19(5):539-545. doi:10.1089/cap.209.042 PubMed
29. DerSimonian R, Laird N. Meta-analysis inclinical trials. Control Clin Trials. 1986;7(3):177-188. doi:10.1016/0197-2456(86)9046-2 PubMed
30. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. PubMed (Pubitemid 27387172)